Urinary flavonoid excretion and risk of acute coronary syndrome in a nested case-control study

American Journal of Clinical Nutrition

Volumn 98, Issue 1, 2013, Pages 209-216

  Bredsdorff, Lea ^a,b   Obel, Tina ^c   Dethlefsen, Claus ^c   Tjønneland, Anne ^d   Schmidt, Erik B ^c   Rasmussen, Salka E ^e   Overvad, Kim ^c,f  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^e NOVO NORDISK A S   (Denmark)

^f AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; DAIDZEIN; FLAVONOID; FLAVONOL DERIVATIVE; GENISTEIN; HESPERETIN; ISORHAMNETIN; KAEMPFEROL; NARINGENIN; PHLORETIN; QUERCETIN; QUERCETIN DERIVATIVE; TAMARIXETIN; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY RISK; CORRELATIONAL STUDY; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; RISK REDUCTION; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

ACUTE CORONARY SYNDROME; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; DENMARK; DIET; FEMALE; FLAVONOIDS; HUMANS; INCIDENCE; ISOFLAVONES; KAEMPFEROLS; LIFE STYLE; LOGISTIC MODELS; MALE; MASS SPECTROMETRY; MIDDLE AGED; RISK FACTORS;

EID: 84879423050     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.112.046169     Document Type: Article

References (45)

1. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993;342:1007-11.
2. Hertog MGL, Feskens EJM, Kromhout D. Antioxidant flavonols and coronary heart disease risk. Lancet 1997;349:699.
3. Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: A cohort study. BMJ 1996;312:478-81.
4. Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, Aromaa A. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 2002;76:560-8.
5. Hirvonen T, Pietinen P, Virtanen M, Ovaskainen ML, Hakkinen S, Albanes D, Virtamo J. Intake of flavonols and flavones and risk of coronary heart disease in male smokers. Epidemiology 2001;12:62-7.
6. Arts ICW, Hollman PCH, Feskens EJM, de Mesquita HBB, Kromhout D. Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study. Am J Clin Nutr 2001;74:227-32.
7. Geleijnse JM, Launer LJ, van der Kuip DAM, Hofman A, Witteman JCM. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr 2002;75: 880-6.
8. Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA, Jacobs DR. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 2007; 85:895-909.
9. Rimm EB, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med 1996;125:384-9.
10. Hertog MGL, Sweetman PM, Fehily AM, Elwood PC, Kromhout D. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr 1997;65:1489-94.
11. Yochum L, Kushi LH, Meyer K, Folsom AR. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am J Epidemiol 1999;149:943-9.
12. Arts ICW, Jacobs DR, Harnack LJ, Gross M, Folsom AR. Dietary catechins in relation to coronary heart disease death among postmenopausal women. Epidemiology 2001;12:668-75.
13. Lin J, Rexrode KM, Hu F, Albert CM, Chae CU, Rimm EB, Stampfer MJ, Manson JE. Dietary intakes of flavonols and flavones and coronary heart disease in US women. Am J Epidemiol 2007;165:1305-13.
14. Erdman JW, Balentine D, Arab L, Beecher G, Dwyer JT, Folts J, Harnly J, Hollman P, Keen CL, Mazza G, et al. Flavonoids and heart health: proceedings of the ILSI North America Flavonoids Workshop, May 31- June 1, 2005, Washington, DC. J Nutr 2007;137(3 suppl 1):718Ss-37S.
15. Sies H. Polyphenols and health: update and perspectives. Arch Biochem Biophys 2010;501:2-5.
16. Häkkinen SH, Karenlampi SO, Mykkanen HM, Torronen AR. Influence of domestic processing and storage on flavonol contents in berries. J Agric Food Chem 2000;48:2960-5.
17. Mikkonen TP, Maatta KR, Hukkanen AT, Kokko HI, Torronen AR, Karenlampi SO, Karjalainen RO. Flavonol content varies among black currant cultivars. J Agric Food Chem 2001;49:3274-7.
18. DuPont MS, Mondin Z, Williamson G, Price KR. Effect of variety, processing, and storage on the flavonoid glycoside content and composition of lettuce and endive. J Agric Food Chem 2000;48:3957-64.
19. Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 2002;22:19-34.
20. Cermak R, Durazzo A, Maiani G, Bohm V, Kammerer DR, Carle R, Wiczkowski W, Piskula MK, Galensa R. The influence of postharvest processing and storage of foodstuffs on the bioavailability of flavonoids and phenolic acids. Mol Nutr Food Res 2009;53(suppl 2):S184-93.
21. Crozier A, Jaganath IB, Clifford MN. Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep 2009;26:1001-43.
22. Tjønneland A, Olsen A, Boll K, Stripp C, Christensen J, Engholm G, Overvad K. Study design, exposure variables, and socioeconomic determinants of participation in diet, cancer and health: a populationbased prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 2007;35:432-41.
23. Ernster VL. Nested case-control studies. Prev Med 1994;23:587-90.
24. Joensen AM, Jensen MK, Overvad K, Dethlefsenc C, Schmidt E, Rasmussen L, Tjønneland A, Johnsen S. Predictive values of acute coronary syndrome discharge diagnoses differed in the Danish National Patient Registry. J Clin Epidemiol 2009;62:188-94.
25. Jensen MK, Rimm EB, Mukamal KJ, Edmondson AC, Rader DJ, Vogel U, Tjønneland A, Sorensen TIA, Schmidt EB, Overvad K. The T111I variant in the endothelial lipase gene and risk of coronary heart disease in three independent populations. Eur Heart J 2009;30:1584-9.
26. Jensen MK, Rimm EB, Rader D, Schmidt EB, Sorensen TIA, Vogel U, Overvad K, Mukamal KJ. S447X variant of the lipoprotein lipase gene, lipids, and risk of coronary heart disease in 3 prospective cohort studies. Am Heart J 2009;157:384-90.
27. Vogel U, Segel S, Dethlefsen C, Tjønneland A, Saber AT, Wallin H, Jensen MK, Schmidt EB, Andersen PS, Overvad K. Associations between COX-2 polymorphisms, blood cholesterol and risk of acute coronary syndrome. Atherosclerosis 2010;209:155-62.
28. Vogel U, Segel S, Dethlefsen C, Tjønneland A, Saber AT, Wallin H, Jensen MK, Schmidt EB, Andersen PS, Overvad K. PPARgamma Pro (12)Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes. BMC Med Genet 2009;10:52.
29. Overvad K, Tjønneland A, Haraldsdottir J, Ewertz M, Jensen OM. Development of a semiquantitative food frequency questionnaire to assess food, energy and nutrient intake in Denmark. Int J Epidemiol 1991;20:900-5.
30. Tjønneland A, Overvad K, Haraldsdottir J, Bang S, Ewertz M, Jensen OM. Validation of a semiquantitative food frequency questionnaire developed in Denmark. Int J Epidemiol 1991;20:906-12.
31. Nielsen ILF, Chee WSS, Poulsen L, Offord-Cavin E, Rasmussen SE, Frederiksen H, Enslen M, Barron D, Horcajada MN, Williamson G. Bioavailability is improved by enzymatic modification of the citrus flavonoid hesperidin in humans: a randomized, double-blind, crossover trial. J Nutr 2006;136:404-8.
32. Nielsen SE, Freese R, Cornett C, Dragsted LO. Identification and quantification of flavonoids in human urine samples by column switching liquid chromatography coupled to atmospheric pressure chemical ionization mass spectrometry. Anal Chem 2000;72:1503-9.
33. McCullough ML, Peterson JJ, Patel R, Jacques PF, Shah R, Dwyer JT. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr 2012;95:454-64.
34. Johnsen SP, Overvad K, Stripp C, Tjønneland A, Husted SE, Sorensen HT. Intake of fruit and vegetables and the risk of ischemic stroke in a cohort of Danish men and women. Am J Clin Nutr 2003;78:57-64.
35. Hertog MGL, Hollman PCH, Vandeputte B. Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices. J Agric Food Chem 1993;41:1242-6.
36. Hertog MGL, Hollman PCH, Katan MB. Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J Agric Food Chem 1992;40:2379-83.
37. Calderón-Montaño JM, Burgos-Moron E, Perez-Guerrero C, Lopez-Lazaro M. A review on the dietary flavonoid kaempferol. Mini Rev Med Chem 2011;11:298-344.
38. Grace PB, Taylor JI, Low YL, Luben RN, Mulligan AA, Botting NP, Dowsett M, Welch AA, Khaw KT, Wareham NJ, et al. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European Prospective Investigation of Cancer and Nutrition-Norfolk. Cancer Epidemiol Biomarkers Prev 2004;13:698-708.
39. Zhang X, Gao YT, Yang G, Li H, Cai Q, Xiang YB, Ji BT, Franke AA, Zheng W, Shu XO. Urinary isoflavonoids and risk of coronary heart disease. Int J Epidemiol 2012;41:1367-75.
40. Mortensen A, Kulling SE, Schwartz H, Rowland I, Ruefer CE, Rimbach G, Cassidy A, Magee P, Millar J, Hall WL, et al. Analytical and compositional aspects of isoflavones in food and their biological effects. Mol Nutr Food Res 2009;53(suppl 2):S266-309.
41. Cano A, Garcia-Perez MA, Tarin JJ. Isoflavones and cardiovascular disease. Maturitas 2010;67:219-26.
42. Krogholm KS, Bysted A, Brantsaeter AL, Jakobsen J, Rasmussen SE, Kristoffersen L, Toft U. Evaluation of flavonoids and enterolactone in overnight urine as intake biomarkers of fruits, vegetables and beverages in the Inter99 cohort study using the method of triads. Br J Nutr 2012; 108:1904-12.
43. Manach C, Williamson G, Morand C, Scalbert A, Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005;81(1 suppl):230S-42S.
44. Hollman PCH, Bijsman MNCP, van Gameren Y, Cnossen EPJ, de Vries JHM, Katan MB. The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Radic Res 1999; 31:569-73.
45. Bredsdorff L, Nielsen ILF, Rasmussen SE, Cornett C, Barron D, Bouisset F, Offord E, Williamson G. Absorption, conjugation and excretion of the flavanones, naringenin and hesperetin from alpharhamnosidase-treated orange juice in human subjects. Br J Nutr 2010; 103:1602-9.